BRAINSTORM CELL THERAPEUTICS (BCLI) Stock Cash Flow
NASDAQ:BCLI - Nasdaq - US10501E3009 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -14.23M | -17.19M | -24.28M | -24.46M | -31.81M | |||
| Depreciation Amortization | 252.00K | 265.00K | 290.00K | 260.00K | 220.00K | |||
| Change In Working Capital | -238.00K | -496.00K | 2.99M | -3.43M | -6.32M | |||
| Other non cash items | 2.88M | -3.04M | 1.68M | 1.37M | 2.72M | |||
| OPERATING CASH FLOW | -11.33M | -20.46M | -19.32M | -26.27M | -35.19M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -18.00K | -30.00K | -330.00K | -380.00K | |||
| Other Investing Activity | N/A | 2.21M | 1.03M | 650.00K | -4.07M | |||
| INVESTING CASH FLOW | N/A | 2.19M | 1.00M | 320.00K | -4.45M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 10.26M | 18.98M | 240.00K | 6.97M | 76.94M | |||
| FINANCING CASH FLOW | 10.26M | 18.98M | 240.00K | 6.97M | 76.94M | |||
| CHANGE IN CASH | -883.00K | 713.00K | -18.08M | -18.98M | 37.30M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -11.33M | -20.46M | -19.32M | -26.27M | -35.19M | |||
| Capital Expenditure | N/A | -18.00K | -30.00K | -330.00K | -380.00K | |||
| FREE CASH FLOW | -11.33M | -20.48M | -19.35M | -26.60M | -35.57M | |||
All data in USD